Novo, Roche, GlaxoSmithKline and Novartis, all of which participated in a $41m round for Alios in April, exited the pharmaceutical company, which was bought by Johnson & Johnson.
Month: September 2014
Vitae aims to improve its life with $55m IPO
The pharmaceutical company, backed by Allergan and Boehringer Ingelheim, raised the cash after $109m of equity funding.
Novo backs Adaptimmune for $104m series A
Adaptimmune, which focuses on the use of T-cell therapy to treat cancer and infectious diseases, has completed a huge series A round to expand its clinical trials.
Corporates join forces for Fab Orange accelerator
France-based telecommunications company Orange has secured corporate partners for the fourth year of Orange Fab, its US-based accelerator programme. Electronics manufacturer LG, payment services firm Visa, hospitality company Hilton, retailer Fnac and drinks company Moët Hennessy will all be participating in the initiative. Orange Fab invests $20,000 in six to nine start-up companies, twice a… Continue reading Corporates join forces for Fab Orange accelerator
Healthcare comparison company WiserTogether raises $9m
WiserTogether has raised $9m in a series B round that featured Merck’s corporate venturing unit, and which will be used to scale its operations.
Bionym idenitifies Salesforce and MasterCard for series A
Biometric authentification company Bionym has secured $14m from a series A round backed by Salesforce.com and MasterCard.
Online connectivity company Accuris raises $15m
Accuris Networks, a provider of a cellular and wifi connectivity platform, has raised $15m in funding and appointed a new chief executive, Jeff Brown.
Hootsuite closes $60m series C
The Hearst-backed social relationship company has now secured $250m in total, at a valuation double that at which it raised $165m last year.
Credit Karma raises $75m at $1bn valuation
The credit monitoring company increased its overall funding to nearly $200m and its valuation above the $1bn mark after raising a new round backed by Google’s growth capital unit.
WaterHealth flows into $10m
The water purification company’s existing investors include Dow, Coca-Cola and Tata.
GSK and Avalon invest $20m in new firms
Silarus Therapeutics and Thyritiope Biosciences are the second and third companies to emerge from the firms’ $495m life sciences incubation partnership.
Johnson & Johnson helps Inivata detect $6m
Cancer diagnostics company Inivata, which works with technology spun-out from Cancer Research UK, has received $6m in its first external venture round.
BetterWorks takes series A past $25m
Enterprise goals platform Betterworks has raised $15.5m in a second tranche of series A funding from Formation 8, Kleiner Perkins, AME Cloud Ventures and Pejman Mar Ventures.
NexSteppe refuels for $22m series C
Total and DuPont both contributed to a $22m round for the company, which develops crops that can be used as biofuel feedstock.